Moderna , Inc. (NASDAQ:MRNA) today confirmed that it has won a tender to supply its mRNA COVID-19 vaccine in the European Union (EU), Norway, and North Macedonia. The agreement, valid for up to four ...

Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, ...

A new experimental vaccine developed by researchers at MIT and Caltech could offer protection against emerging variants of SARS-CoV-2, as well as related coronaviruses, known as sarbecoviruses, that ...

Here's what we know about the virus today, five years after the first nation's case of COVID-19 was reported north of Seattle ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats ...

When virologists took their first peek at XEC, the Covid-19 variant which started to become dominant in the autumn of 2024, the early signs were ominous. The latest descendant of the Omicron ...

According to Dr. Dawn Nolt, a pediatric infectious disease physician at Oregon Health and Science University, many of the ...

Invivyd Inc. (NASDAQ:IVVD) announced that new in vitro neutralization data show continued neutralizing activity of Pemgarda ...

The new Omicron variant is expected to infect 60 per cent of people in China in the coming three months. Symptoms of COVID-19 can range from mild to severe, and can include fever, cough ...

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...

Stay informed about COVID-19 symptoms in 2025, including new variants like XEC. Understand how to differentiate between COVID ...